{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T13:59:40Z","timestamp":1778075980048,"version":"3.51.4"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100001845","name":"Scleroderma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001845","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Martha McCrory Professorship"},{"name":"Chresanthe Stauralakis Memorial Discovery Fund"},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32AR048522"],"award-info":[{"award-number":["T32AR048522"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR073208"],"award-info":[{"award-number":["R01AR073208"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24AR080217"],"award-info":[{"award-number":["K24AR080217"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AR070254"],"award-info":[{"award-number":["P30AR070254"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cohn Family Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Ectopic calcification (calcinosis) is a common complication of SSc, but a subset of SSc patients has a heavy burden of calcinosis. We examined whether there are unique risk factors for a heavy burden of calcinosis, as compared with a light burden or no calcinosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We reviewed the medical records of all patients in the Johns Hopkins Scleroderma Center Research Registry with calcinosis to quantify calcinosis burden using pre-specified definitions. We performed latent class analysis to identify SSc phenotypic classes. We used multinomial logistic regression to determine whether latent phenotypic classes and autoantibodies were independent risk factors for calcinosis burden.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of all patients, 29.4% (997\/3388) had calcinosis, and 13.5% (130\/963) of those with calcinosis had a heavy burden. The latent phenotypic class with predominantly diffuse skin disease and higher disease severity (characterized by pulmonary hypertension, interstitial lung disease, cardiomyopathy, severe RP, gastrointestinal involvement, renal crisis, myopathy and\/or tendon friction rubs) was associated with an increased risk of both a heavy burden [odds ratio (OR) 6.92, 95% CI 3.66, 13.08; P\u2009&amp;lt;\u20090.001] and a light burden (OR 2.88, 95% CI 2.11, 3.95; P\u2009&amp;lt;\u20090.001) of calcinosis compared with the phenotypic class with predominantly limited skin disease. Autoantibodies to PM\/Scl were strongly associated with a heavy burden of calcinosis (OR 17.31, 95% CI 7.72, 38.81; P\u2009&amp;lt;\u20090.001) and to a lesser degree a light burden of calcinosis (OR 3.59, 95% CI 1.84, 7.00; P\u2009&amp;lt;\u20090.001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Calcinosis burden is associated with cumulative SSc-related tissue damage. Independent of disease severity, autoantibodies to PM\/Scl are also associated with a heavy burden of calcinosis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac682","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T20:07:09Z","timestamp":1670270829000},"page":"3636-3643","source":"Crossref","is-referenced-by-count":11,"title":["Cumulative disease damage and anti-PM\/Scl antibodies are associated with a heavy burden of calcinosis in systemic sclerosis"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2541-175X","authenticated-orcid":false,"given":"Carrie","family":"Richardson","sequence":"first","affiliation":[{"name":"Department of Medicine (Rheumatology), Northwestern University , Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Perin","sequence":"additional","affiliation":[{"name":"Department of International Health, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Zeger","sequence":"additional","affiliation":[{"name":"Departments of Biostatistics, Epidemiology and International Health, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrick M","family":"Wigley","sequence":"additional","affiliation":[{"name":"Department of Medicine (Rheumatology), Johns Hopkins University School of Medicine , Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura K","family":"Hummers","sequence":"additional","affiliation":[{"name":"Department of Medicine (Rheumatology), Johns Hopkins University School of Medicine , Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livia","family":"Casciola-Rosen","sequence":"additional","affiliation":[{"name":"Department of Medicine (Rheumatology), Johns Hopkins University School of Medicine , Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antony","family":"Rosen","sequence":"additional","affiliation":[{"name":"Department of Medicine (Rheumatology), Johns Hopkins University School of Medicine , Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1139-2009","authenticated-orcid":false,"given":"Ami A","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Medicine (Rheumatology), Johns Hopkins University School of Medicine , Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"key":"2023110720055635900_keac682-B1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/03009742.2016.1219766","article-title":"X-ray diffraction analysis of spontaneously draining calcinosis in scleroderma patients","volume":"46","author":"Hsu","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"2023110720055635900_keac682-B2","first-page":"242","article-title":"Ultrastructural and crystallographic study of calcifications from a patient with CREST syndrome","volume":"10","author":"Leroux","year":"1983","journal-title":"J Rheumatol"},{"key":"2023110720055635900_keac682-B3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.semarthrit.2016.05.008","article-title":"Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: a Scleroderma Clinical Trials Consortium study","volume":"46","author":"Valenzuela","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"2023110720055635900_keac682-B4","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/acr.22672","article-title":"Late nailfold videocapillaroscopy pattern associated with hand calcinosis and acro-osteolysis in systemic sclerosis","volume":"68","author":"Morardet","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2023110720055635900_keac682-B5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.semarthrit.2018.02.005","article-title":"Does nailfold capillaroscopy help predict future outcomes in systemic sclerosis? A systematic literature review","volume":"48","author":"Paxton","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"2023110720055635900_keac682-B6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.humpath.2005.10.007","article-title":"The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis","volume":"37","author":"Davies","year":"2006","journal-title":"Hum Pathol"},{"key":"2023110720055635900_keac682-B7","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1080\/14397595.2021.1886654","article-title":"Prevalence and clinical association with calcinosis cutis in early systemic sclerosis","volume":"31","author":"Muktabhant","year":"2021","journal-title":"Mod Rheumatol"},{"key":"2023110720055635900_keac682-B8","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.semarthrit.2020.06.007","article-title":"Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosis","volume":"50","author":"Valenzuela","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2023110720055635900_keac682-B9","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/acr.24327","article-title":"Ultrasound detection of calcinosis and association with ulnar artery occlusion in patients with systemic sclerosis","volume":"73","author":"Fairchild","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2023110720055635900_keac682-B10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/1756-185X.14121","article-title":"Characteristics of Japanese patients with systemic sclerosis complicated with calcinosis","volume":"24","author":"Takagi","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"2023110720055635900_keac682-B11","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/acr.23413","article-title":"Combination of capillaroscopic and ultrasonographic evaluations in systemic sclerosis: results of a cross-sectional study","volume":"70","author":"Lescoat","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2023110720055635900_keac682-B12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10067-016-3412-9","article-title":"Clinical, biochemical, and radiological characterization of the calcinosis in a cohort of Mexican patients with systemic sclerosis","volume":"36","author":"Cruz-Dom\u00ednguez","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2023110720055635900_keac682-B13","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1080\/14397595.2017.1349594","article-title":"Are there risk factors for scleroderma-related calcinosis?","volume":"28","author":"Pai","year":"2018","journal-title":"Mod Rheumatol"},{"key":"2023110720055635900_keac682-B14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/03009742.2015.1086432","article-title":"History of surgical debridement, anticentromere antibody, and disease duration are associated with calcinosis in patients with systemic sclerosis","volume":"45","author":"Mahmood","year":"2016","journal-title":"Scand J Rheumatol"},{"key":"2023110720055635900_keac682-B15","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/art.38428","article-title":"Clinical and serologic correlates of anti-PM\/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients","volume":"66","author":"D\u2019Aoust","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2023110720055635900_keac682-B16","first-page":"581","article-title":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","volume":"23","author":"Preliminary Criteria for the Classification of Systemic Sclerosis (Scleroderma)","year":"1980","journal-title":"Arthritis Rheum"},{"key":"2023110720055635900_keac682-B17","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2023110720055635900_keac682-B18","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1002\/art.24038","article-title":"Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud\u2019s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis","volume":"58","author":"Koenig","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2023110720055635900_keac682-B19","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/annrheumdis-2012-202849","article-title":"The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis","volume":"73","author":"Cottrell","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2023110720055635900_keac682-B20","first-page":"2159","article-title":"A disease severity scale for systemic sclerosis: development and testing","volume":"26","author":"Medsger","year":"1999","journal-title":"J Rheumatol"},{"key":"2023110720055635900_keac682-B21","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2023110720055635900_keac682-B22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/rheumatology\/keh067","article-title":"Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis","volume":"43","author":"Mukerjee","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"2023110720055635900_keac682-B23","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1002\/art.39316","article-title":"Interpretation of an extended autoantibody profile in a well-characterized Australian systemic sclerosis (scleroderma) cohort using principal components analysis","volume":"67","author":"Patterson","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2023110720055635900_keac682-B24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/art.41153","article-title":"Using autoantibodies and cutaneous subset to develop outcome-based disease classification in systemic sclerosis","volume":"72","author":"Nihtyanova","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2023110720055635900_keac682-B25","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/art.40906","article-title":"Phenotypes determined by cluster analysis and their survival in the prospective european scleroderma trials and research cohort of patients with systemic sclerosis","volume":"71","author":"Sobanski","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2023110720055635900_keac682-B26","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1080\/01621459.1997.10473658","article-title":"Latent variable regression for multiple discrete outcomes","volume":"92","author":"Bandeen-roche","year":"1997","journal-title":"J Am Stat Assoc"},{"key":"2023110720055635900_keac682-B27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v045.i03","article-title":"mice: Multivariate imputation by chained equations in R","volume":"45","author":"Buuren","year":"2011","journal-title":"J Stat Softw"},{"key":"2023110720055635900_keac682-B28","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1093\/rheumatology\/keab152","article-title":"The clinical phenotype of systemic sclerosis patients with anti-PM\/Scl antibodies: results from the EUSTAR cohort","volume":"60","author":"Lazzaroni","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2023110720055635900_keac682-B29","first-page":"80","article-title":"The clinical relevance of autoantibodies in scleroderma","volume":"5","author":"Ho","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"2023110720055635900_keac682-B30","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/08916934.2015.1077231","article-title":"Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects","volume":"48","author":"Wodkowski","year":"2015","journal-title":"Autoimmunity"},{"key":"2023110720055635900_keac682-B31","first-page":"303","article-title":"Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options","volume":"35","author":"Fredi","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"2023110720055635900_keac682-B32","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/art.1780351014","article-title":"Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations","volume":"35","author":"Oddis","year":"1992","journal-title":"Arthritis Rheum"},{"key":"2023110720055635900_keac682-B33","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/rheumatology\/keaa332","article-title":"High proton pump inhibitor exposure increases risk of calcinosis in systemic sclerosis","volume":"60","author":"Host","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2023110720055635900_keac682-B34","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/jnci\/85.3.230","article-title":"Mammographic calcifications and risk of subsequent breast cancer","volume":"85","author":"Thomas","year":"1993","journal-title":"J Natl Cancer Inst"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac682\/48342879\/keac682.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/11\/3636\/52794566\/keac682.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/11\/3636\/52794566\/keac682.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T20:21:03Z","timestamp":1699388463000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/11\/3636\/6873735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":34,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,12,5]]},"published-print":{"date-parts":[[2023,11,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac682","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11,1]]},"published":{"date-parts":[[2022,12,5]]}}}